Expression of bcl-2 family members in malignant pleural mesothelioma. - Wikidata - wikimedia - TriplyDB

Expression of bcl-2 family members in malignant pleural mesothelioma.

Expression of bcl-2 family members in malignant pleural mesothelioma.

http://www.wikidata.org/entity/Q38437441

about

BAK and NOXA are critical determinants of mitochondrial apoptosis induced by bortezomib in mesothelioma hsa-miR-29c* is linked to the prognosis of malignant pleural mesothelioma.Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities Expression of Bim, Noxa, and Puma in non-small cell lung cancer Resveratrol and clofarabine induces a preferential apoptosis-activating effect on malignant mesothelioma cells by Mcl-1 down-regulation and caspase-3 activation.Does the expression of BCL2 have prognostic significance in malignant peritoneal mesothelioma?Expression of cancer-associated molecules in malignant mesothelioma MicroRNA-302b targets Mcl-1 and inhibits cell proliferation and induces apoptosis in malignant pleural mesothelioma cells Biomarkers for malignant pleural mesothelioma: current status.New diagnostic and molecular characteristics of malignant mesothelioma.Inhibition of Mcl-1 expression by citrate enhances the effect of Bcl-xL inhibitors on human ovarian carcinoma cells.Blocking of ERK1 and ERK2 sensitizes human mesothelioma cells to doxorubicin.Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy.p53 Expression in a Malignant Mesothelioma Patient during Seven-Year Follow-up.

P2860

Q28533736-2B1BA79E-B623-4FDE-BF6A-4887F4FC0C5F Q33699231-FEE910BB-1D15-4E96-ACCD-DFB860E599F7 Q34139691-A07C2581-1B0C-4206-9D95-20A77327117F Q34334492-BF5EDFD8-1B00-40B6-8DAE-C5F4159E0167 Q35676344-FCBEDCAB-AEBB-43B1-BC63-1C7135E78B75 Q36966828-BA36F841-94EA-42C3-BAE0-E594D8B6A181 Q37281015-2924599B-E77A-49D7-9DED-888503F86724 Q37298299-54C9A95B-301E-49D3-89F3-E4258A2E66C5 Q37335377-369AE112-751E-4966-B77A-E812540A13FF Q37360580-175BB1CE-CCB3-4CDD-9D1C-926C49B654B5 Q37365582-1582ADA2-9C6D-459B-ADD2-4E9C829F2E31 Q39620039-B70C70F1-212B-47CE-ACC9-584D08C69000 Q39741953-5F3325A1-6A51-473A-A999-48CBFF6A580C Q41849387-1CE43AB9-A032-4FE3-8455-EA7EA8B84B53

P2860

Expression of bcl-2 family members in malignant pleural mesothelioma.

http://www.wikidata.org/entity/Q38437441

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Expression of bcl-2 family members in malignant pleural mesothelioma.

@en

type

label

Expression of bcl-2 family members in malignant pleural mesothelioma.

@en

prefLabel

Expression of bcl-2 family members in malignant pleural mesothelioma.

@en

P1433

Q38437441-B10EBF0F-08F5-4685-AE9B-7D33F0E14799

P1476

Q38437441-F522FCBB-AED3-4FFE-8D1D-C04AAAB582A5

P2093

Q38437441-168FC6E4-2EA2-4866-BF8A-7EE037064001

Q38437441-3BC85A97-5E8A-477C-BBDE-D1B207C8A80F

Q38437441-40DA44F9-90EA-44AB-B31C-3DA385252E9F

Q38437441-5F6643E9-5400-4918-ACF4-F441C5E8A575

Q38437441-7647CFBB-3259-461B-B370-CCB402B0A119

Q38437441-FCE269DF-552D-4533-AD4C-0B7870119E36

P2860

Q38437441-13DD8290-86EB-4275-99DC-B103A413A82E

Q38437441-178C99B3-666E-4AD5-A2CE-4490F1D17DD0

Q38437441-2A91FFB2-0CAF-4823-A0C1-A14CA5F9D632

Q38437441-3AFCBC9A-2316-4EFD-9D89-5D7B800C3597

Q38437441-3FD978AF-70A2-45E7-B11F-FE131EEA8DE5

Q38437441-6245B26F-4529-44B6-9A6B-69974E6AF869

Q38437441-62A91610-8E5C-4965-A5EC-47B123FB0E8C

Q38437441-7B8ED0B7-2656-42B5-A5FE-086A5DC4CC94

Q38437441-8587C524-6337-449E-9F55-F191BFE06020

Q38437441-8F145635-5B3E-4DD7-B403-24C448C6FB42

P304

Q38437441-00582ADE-85FF-42DE-BBFD-7CE21D7824A3

P31

Q38437441-637FFCB5-87BB-4ECE-BBE1-7318D79937E3

P356

Q38437441-22515704-9D43-4919-990B-53F626F31DF1

P433

Q38437441-590AFAD9-C3A9-49E9-8B40-31A300175D79

P478

Q38437441-D205AD08-F25F-4E3C-94E5-15F224EBF75A

P577

Q38437441-62E1E660-8751-4CB2-A4F0-39E4AE69713E

P5875

Q38437441-E94C552A-8E51-4D07-97B9-570E96F6EB0B

P698

Q38437441-11D465E0-97DC-4F7A-AC6C-44E336DD7F36

P356

02841860500468927

P1433

Acta Oncologica

P1476

Expression of bcl-2 family members in malignant pleural mesothelioma.

@en

P2093

Anne Campbell

http://www.w3.org/2001/XMLSchema#string

Lynn Cawkwell

http://www.w3.org/2001/XMLSchema#string

Michael J Lind

http://www.w3.org/2001/XMLSchema#string

Nilanjan Chaudhuri

http://www.w3.org/2001/XMLSchema#string

Rachelle J Pound

http://www.w3.org/2001/XMLSchema#string

Sara L O'Kane

http://www.w3.org/2001/XMLSchema#string

P2860

Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems

The Bcl2 family: regulators of the cellular life-or-death switch

BH3-Only proteins-essential initiators of apoptotic cell death.

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma.

Apoptosis pathways in cancer and cancer therapy.

The role of Bcl-2 family members in tumorigenesis.

The expression of Bcl-2 family proteins differs between nonsmall cell lung carcinoma subtypes.

Choice of management strategy for colorectal cancer based on a diagnostic immunohistochemical test for defective mismatch repair.

p53 expression is common in malignant mesothelioma.

Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B.

P304

449-453

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/02841860500468927

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2006-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7023321

http://www.w3.org/2001/XMLSchema#string

P698

16760181

http://www.w3.org/2001/XMLSchema#string